Home Articles & Issues Published Ahead-of-Print CME Collections ABOG MOC II Podcasts Videos Journal Info
Skip Navigation LinksHome > April 2001 - Volume 97 - Issue 4 > Pregnancy‐Related Mortality From Preeclampsia and Eclampsia
Obstetrics & Gynecology:
Original Research

Pregnancy‐Related Mortality From Preeclampsia and Eclampsia

MACKAY, ANDREA P. MSPH; BERG, CYNTHIA J. MD, MPH; ATRASH, HANI K. MD, MPH

Free Access
Article Outline
Collapse Box

Author Information

Office of Analysis, Epidemiology, and Health Promotion, National Center for Health Statistics, Hyattsville, Maryland, and Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Address reprint requests to: Andrea P. MacKay, MSPH, National Center for Health Statistics, 6525 Belcrest Road, Room 790, Hyattsville, MD 20782. E-mail: anm3@cdc.gov

Received August 17, 2000. Received in revised form November 28, 2000. Accepted December 7, 2000.

Collapse Box

Abstract

Objective: To examine the role of preeclampsia and eclampsia in pregnancy-related mortality.

Methods: We used data from the Centers for Disease Control and Prevention's Pregnancy Mortality Surveillance System to examine pregnancy-related deaths from preeclampsia and eclampsia from 1979 to 1992. The pregnancy-related mortality ratio for preeclampsia-eclampsia was defined as the number of deaths from preeclampsia and eclampsia per 100,000 live births. Case-fatality rates for 1988–1992 were calculated for preeclampsia and eclampsia deaths per 10,000 cases during the delivery hospitalization, using the National Hospital Discharge Survey.

Results: Of 4024 pregnancy-related deaths at 20 weeks' or more gestation in 1979–1992, 790 were due to preeclampsia or eclampsia (1.5 deaths/100,000 live births). Mortality from preeclampsia and eclampsia increased with increasing maternal age. The highest risk of death was at gestational age 20–28 weeks and after the first live birth. Black women were 3.1 times more likely to die from preeclampsia or eclampsia as white women. Women who had received no prenatal care had a higher risk of death from preeclampsia or eclampsia than women who had received any level of prenatal care. The overall preeclampsia-eclampsia case-fatality rate was 6.4 per 10,000 cases at delivery, and was twice as high for black women as for white women.

Conclusion: The continuing racial disparity in mortality from preeclampsia and eclampsia emphasizes the need to identify those differences that contribute to excess mortality among black women, and to develop specific interventions to reduce mortality from preeclampsia and eclampsia among all women.

Pregnancy-induced or aggravated hypertension is an important complication of pregnancy and a leading cause of pregnancy-related death in the United States. The reported incidence of hypertension, including preeclampsia, eclampsia, and superimposed preeclampsia and eclampsia among all pregnant women varies from approximately 3% to 10%.1–3 Hypertension was reported to account for 15% of all antenatal hospitalizations for pregnancy complications.4 Women who develop preeclampsia or eclampsia during pregnancy are at an increased risk of abruptio placentae, acute renal failure, cerebrovascular and cardiovascular complications, and maternal death.3,5

We used data from the Centers for Disease Control and Prevention's (CDC) Pregnancy Mortality Surveillance System to conduct an analysis of pregnancy-related mortality from preeclampsia and eclampsia. We reviewed all reported pregnancy-related deaths in the United States for 1979–1992 to understand trends in pregnancy-related mortality associated with complications of preeclampsia and eclampsia, to identify risk factors for these deaths, and to calculate case-fatality rates.

Back to Top | Article Outline

Materials and Methods

CDC's Division of Reproductive Health, in collaboration with ACOG and state health departments, conducts ongoing surveillance of pregnancy-related deaths. Health departments in the 50 states, the District of Columbia, and New York City provide CDC with copies of death certificates and, when available, matched birth or fetal death certificates for all identified pregnancy-related deaths. The present analysis includes data from 1979 to 1992, the most recent years for which completed data are available.

Deaths were considered pregnancy-related if they occurred during pregnancy or within 1 year of the termination of pregnancy and resulted from complications of pregnancy itself, a chain of events initiated by pregnancy, or aggravation of an unrelated event by the physiologic effects of pregnancy. Information on all pregnancy deaths was reviewed and coded by clinically experienced epidemiologists for cause of death, contributing conditions of death, and outcome of the pregnancy. Deaths were classified using the system designed in collaboration with the CDC/ACOG Maternal Mortality Study Group. Pregnancy-related mortality ratios were defined as the number of pregnancy-related deaths per 100,000 live births. The number of live births was obtained from public-use tapes maintained by CDC's National Center for Health Statistics.

We included deaths from preeclampsia, eclampsia, and chronic hypertension with superimposed preeclampsia or eclampsia in this analysis. Deaths from complications of preexisting, chronic hypertension not aggravated by pregnancy were excluded. We limited the analysis to women with pregnancies at gestational age 20 weeks or greater. We also reviewed deaths from other causes when preeclampsia or eclampsia was a contributory cause of death.

Race-specific mortality for women classified as other than white or black was not analyzed because of small numbers. We examined live birth order as a proxy for parity. Information on live birth order, reported on birth certificates, was available for deaths associated with live births. Information on prenatal care, available for women who died after a live birth, was assessed by using a modification of the Kotelchuck Prenatal Care Utilization Index,6 which combined “intermediate” and “inadequate” care and added a category for women who received no prenatal care. Deaths from states not reporting one or more of the variables needed to calculate the prenatal care utilization index (timing of first prenatal care visit, number of prenatal care visits, and gestational age) were excluded from the analysis of prenatal care for those years during which they did not report (Texas, 1979; New Mexico, 1979–1985; California, 1979–1988).

We defined preeclampsia-eclampsia case-fatality rates as the number of deaths with preeclampsia or eclampsia as the underlying cause of death per 10,000 cases of preeclampsia or eclampsia during the delivery hospitalization. The numerator was the sum of these deaths from the Pregnancy Mortality Surveillance System for 1988–1992. The estimated number of delivery hospitalizations with a diagnosis of preeclampsia or eclampsia for 1988–1992 was obtained from the National Hospital Discharge Survey, an annual multistage probability sample of discharges from nonfederal, short-stay hospitals in the United States. Cases of preeclampsia or eclampsia at delivery were identified using International Classification of Diseases, Ninth Revision codes; we restricted case selection to hospitalizations that indicated a live birth or stillbirth and preeclampsia, eclampsia, or superimposed preeclampsia or eclampsia (ICD-9 codes 642.3–642.7).

Back to Top | Article Outline

Results

For the 14-year study period, we identified 4024 pregnancy-related deaths to women at 20 weeks' or greater gestation; 790 of these deaths (19.6%) were from complications of preeclampsia or eclampsia. The pregnancy-related mortality ratio for deaths from preeclampsia and eclampsia was 1.5 pregnancy-related deaths per 100,000 live births; the overall pregnancy-related mortality ratio for deaths occurring at 20 weeks' or greater gestation was 7.5/100,000. The most frequent causes of pregnancy-related death were embolism, hemorrhage, and preeclampsia or eclampsia (Table 1).

Table 1
Table 1
Image Tools

Approximately half (51%) of preeclampsia-eclampsia deaths were associated with preeclampsia, the remainder with eclampsia. The largest percentage of preeclampsia and eclampsia deaths was attributed to cerebrovascular complications, primarily cerebrovascular hemorrhage (Table 2). Renal or hepatic failure was also frequently listed as the cause of death. Disseminated intravascular coagulation was a contributing condition in 15% of hypertension deaths.

Table 2
Table 2
Image Tools

Preeclampsia or eclampsia was a contributing condition of death in 4.5% of pregnancy-related deaths because of other causes of death (185 deaths). Approximately 11% of anesthesia deaths, 7% of cardiomyopathy deaths, and 10% of deaths from abruptio placentae were complicated by preeclampsia or eclampsia.

The risk of death from preeclampsia or eclampsia was higher for older women than for younger women (Table 3). Black women were at a greater risk of such deaths than white women. The disparity in the risk of death between white and black women was greatest among women aged 30 to 34 years, with black women having more than four times the risk of white women. Among all women, the risk of death from preeclampsia or eclampsia was highest after the first and fifth or higher live birth (Table 3); however, more than half of such deaths occurred after the first live birth and less than 8% after the fifth or higher. Although 47% of deaths from preeclampsia or eclampsia occurred during or after the 37th week of gestation, the greatest risk of death was among women with pregnancies at 28 or fewer weeks' gestation (Table 3).

Table 3
Table 3
Image Tools

Women who had received no prenatal care had a higher risk of death from preeclampsia or eclampsia than women who had received any prenatal care (Table 3). Among white women the risk of death associated with no prenatal care was 12 times that for adequate care; among black women the risk associated with no care was approximately four times that of adequate care.

The case-fatality rate for deaths from preeclampsia or eclampsia was 6.4 deaths per 10,000 cases at delivery (Table 4); the case-fatality rate for deaths associated with eclampsia (71.6) was strikingly higher than for deaths associated with preeclampsia (3.4). The risk of death for women 35 years and older was more than three times that of women 24 years or younger. Case-fatality rates for black women were twice those for white women; the prevalence of preeclampsia or eclampsia at the delivery hospitalization among black women was 1.4 times that of white women.

Table 4
Table 4
Image Tools
Back to Top | Article Outline

Discussion

The results of this analysis are consistent with findings from previous studies of pregnancy-related mortality in which complications of hypertension were found to be the third leading cause of pregnancy-related death, after hemorrhage and embolism.7 The age-specific mortality ratios for preeclampsia and eclampsia reflect the trend observed in other studies—slightly increased risk for younger women (under 20 years) and markedly increased for older women, especially older black women.7 Hansen8 reported that hypertension is more common and carries an increased risk of death among older pregnant women, contributing to the several-fold increase in overall pregnancy mortality for older women compared with younger women.

Although most women in this analysis died after their first live birth, mortality from preeclampsia or eclampsia is not limited to first pregnancies; 40% of the women who died had a previous live birth. Other studies have found that women with a history of hypertension in a prior pregnancy or with a family history of chronic hypertension are at a greater risk of developing hypertension during pregnancy.9 We could not evaluate the role of these risks, as past medical history and family medical history were not available. Further, we could not evaluate the potentially confounding effects of age and birth order because of relatively small numbers.

The racial disparity in overall pregnancy-related mortality is also seen in hypertension-specific mortality.10–12 The combination of a higher prevalence of preeclampsia and eclampsia among black women and higher case-fatality rates contributed to pregnancy-related mortality rates because of preeclampsia and eclampsia for black women more than three times that of white women.

Women who received no prenatal care were more than seven times as likely to die from complications of preeclampsia or eclampsia as women receiving any prenatal care. Although black and white women who received prenatal care had a lower risk of death than women who received no prenatal care, there was a far greater reduction in the risk of death for white women receiving adequate prenatal care than for black women. This finding may reflect the quality of prenatal care, which is not measured by the Prenatal Care Utilization Index, or may be related to other factors not measurable from the data available. Whereas several studies have suggested that the content of prenatal care may differ for black women and white women,13,14 another study reported that black women receiving prenatal care reported significantly fewer prenatal visits than white women during the 8th and 9th months of pregnancy, those months when preeclampsia onset is most common.15

Although a rare event, onset of severe preeclampsia in the second trimester is associated with a higher risk of maternal and fetal morbidity and mortality.16 We found a dramatic increase in the risk of death for women at 20–32 weeks' gestation compared with women at 36–40 weeks or more. The mortality ratios for black and white women during the second trimester were similar; however, for women at 37–40 weeks' gestation, we found a threefold difference in the risk of death for black women compared with white women. This finding may be a further indication of a disparity in health status and access to and quality of prenatal care.

Cerebral hemorrhage has been reported in as many as 60% of all deaths from eclampsia.17 Seven percent of deaths in this study were attributed to hemolysis, elevated liver enzymes, and low platelet count syndrome, a variant of severe hypertension that results in multiorgan failure, which has cited mortality rates ranging from 2% to 24% of cases.18 Preeclampsia and eclampsia have been associated with an increased risk of abruptio placentae,5 disseminated intravascular coagulation, and acute renal failure.17 Abruptio placentae complicated 4% of the pregnancies of women who died of preeclampsia or eclampsia, more than four times the incidence of abruption at the delivery hospitalization for all women.1

The limitations of this analysis should be considered. Pregnancy-related mortality ratios are underestimated; despite improved ascertainment methods initiated over the study period, more than half of pregnancy-related deaths are not identified through routine surveillance methods.19,20 Preeclampsia and eclampsia are multisystem disorders of unknown etiology; the complex nature of complications may lead to misclassification of the underlying cause of death. Cause of death information was obtained from death certificates; therefore, we could not standardize our definitions. For some women, information about preexisting hypertension or chronic renal disease may not have been provided. Estimates from the National Hospital Discharge Survey are subject to errors associated with the use of medical records, including incorrect diagnoses or coder errors.

Deaths from preeclampsia and eclampsia are often preventable.21 Prenatal care, early detection, and careful monitoring and treatment during pregnancy are essential to prevent serious complications.3 It is important for clinicians to identify women with preexisting hypertensive disorders, a prior history of hypertension, or a family history of hypertension, and to educate women about the early warning signs of preeclampsia. The continuing racial disparity in preeclampsia and eclampsia mortality ratios emphasizes the need to identify those differences that contribute to excess mortality among black women, and to develop specific interventions to reduce mortality from preeclampsia and eclampsia among all women.

Back to Top | Article Outline

References

1. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of hypertension in the United States, 1979–1986. Am J Obstet Gynecol 1990;163:460–5.

2. Burrows RF, Burrows EA. The feasibility of a control population for a randomized control trial of seizure prophylaxis in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1995; 173:929–35.

3. Cunningham FG, MacDonald PC, Gant NF, McDonald PC, Leveno KJ, Gilstrap LC, et al. Williams obstetrics. 20th ed. Norwalk, Connecticut: Appleton & Lange, 1997.

4. Scott CL, Chavez GF, Atrash HK, Taylor DJ, Shah RS, Rowley D. Hospitalizations for severe complications of pregnancy, 1987–1992. Obstet Gynecol 1997;90:225–9.

5. Abdella TN, Sibai BM, Hays JM, Anderson GD. Relationship of hypertensive disease to abruptio placentae. Obstet Gynecol 1984; 63:365–70.

6. Kotelchuck M. An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed adequacy of prenatal care utilization index. Am J Public Health 1994;84:1414–20.

7. Koonin LM, MacKay AP, Berg CJ, Atrash HK, Smith JC. Pregnancy-related mortality surveillance—United States, 1987–1990. MMWR Morb Mortal Wkly Rep CDC Surveill Summ 1997;46(4):17–36.

8. Hansen JP. Older maternal age and pregnancy outcome: A review of the literature. Obstet Gynecol Surv 1986;41:726–42.

9. Sibai BM, El-Nazur A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women; subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986;155:1011–6.

10. Centers for Disease Control. Differences in maternal mortality among black and white women—United States, 1990. MMWR Morb Mortal Wkly Rep 1995;44:6–14.

11. Gillum RF. Epidemiology of hypertension in African American women. Am Heart J 1996;131:385–95.

12. Samadi AR, Mayberry RM, Zaidi AA, Pleasant JC, McGhee N Jr, Rice RJ. Maternal hypertension and associated complications among African-American and other women in the United States. Obstet Gynecol 1996;87:557–63.

13. Kogan MD, Kotelchuck M, Alexander GR, Johnson WE. Racial disparities in reported prenatal care advice from health care providers. Am J Public Health 1994;84:82–8.

14. Brett KM, Schoendorf KC, Kiely JL. Differences between black and white women in the use of prenatal care technologies. Am J Obstet Gynecol 1994;170:41–6.

15. Kogan MD, Kotelchuck M, Johnson S. Racial differences in late prenatal care visits. J Perinatol 1993;13:14–21.

16. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: Recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991;165:1408–12.

17. Beck DW, Menezes MB. Intracerebral hemorrhage in a patient with eclampsia. JAMA 1981;246:1442–3.

18. Sibai BM, Taslimi MM, El-Nazur A, Armon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155:501–9.

19. Centers for Disease Control. Enhanced maternal mortality surveillance—North Carolina, 1988 and 1989. MMWR Morb Mortal Wkly Rep 1991;40:469–71.

20. Centers for Disease Control. Pregnancy-related mortality—Georgia, 1990–1992. MMWR Morb Mortal Wkly Rep 1995;44:93–6.

21. Sachs BP, Brown DA, Driscoll SG, Schulman E, Acker D, Ransil BJ, et al. Maternal mortality in Massachusetts: Trends and prevention. N Engl J Med 1987;316:667–72.

Cited By:

This article has been cited 108 time(s).

American Family Physician
Diagnosis and management of Preeclampsia
Wagner, LK
American Family Physician, 70(): 2317-2324.

American Journal of Obstetrics and Gynecology
Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus
Chakravarty, EF; Colon, I; Langen, ES; Nix, DA; El-Sayed, YY; Genovese, MC; Druzin, ML
American Journal of Obstetrics and Gynecology, 192(6): 1897-1904.
10.1016/j.ajog.2005.02.063
CrossRef
Clinical and Applied Thrombosis-Hemostasis
Coagulation and fibrinolysis in preeclampsia and neonates
Tanjung, MT; Siddik, HD; Hariman, H; Koh, SCL
Clinical and Applied Thrombosis-Hemostasis, 11(4): 467-473.

Hypertension
Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia
Li, ZH; Zhang, Y; Ma, JY; Kapoun, AM; Shao, Q; Kerr, I; Lam, A; O'Young, G; Sannajust, F; Stathis, P; Schreiner, G; Karumanchi, SA; Protter, AA; Pollitt, NS
Hypertension, 50(4): 686-692.
10.1161/HYPERTENSIONAHA.107.092098
CrossRef
Fetal Diagnosis and Therapy
Screening for Placental Insufficiency by Transvaginal Uterine Artery Doppler at 22-24 Weeks of Gestation
Palma-Dias, RS; Fonseca, MMC; Brietzke, E; Fritsch, A; Schlatter, D; Maurmann, CB; Stein, NR; Magalhaes, JAA
Fetal Diagnosis and Therapy, 24(4): 462-469.
10.1159/000178141
CrossRef
Bjog-An International Journal of Obstetrics and Gynaecology
Toll-like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre-eclampsia
Xie, F; Hu, Y; Turvey, SE; Magee, LA; Brunham, RM; Choi, KC; Krajden, M; Leung, PCK; Money, DM; Patrick, DM; Thomas, E; von Dadelszen, P
Bjog-An International Journal of Obstetrics and Gynaecology, 117(1): 99-108.
10.1111/j.1471-0528.2009.02428.x
CrossRef
Journal of Epidemiology
Lifestyles and pre-eclampsia with special attention to cigarette smoking
Ioka, A; Tsukuma, H; Nakamuro, K
Journal of Epidemiology, 13(2): 90-95.

European Journal of Obstetrics Gynecology and Reproductive Biology
Social deprivation and poor access to care as risk factors for severe pre-eclampsia
Haelterman, E; Qvist, R; Barlow, P; Alexander, S
European Journal of Obstetrics Gynecology and Reproductive Biology, 111(1): 25-32.
10.1016/S0301-2115(03)00161-1
CrossRef
Australian & New Zealand Journal of Obstetrics & Gynaecology
Hypertension during pregnancy in South Australia, Part 1: Pregnancy outcomes
Heard, AR; Dekker, GA; Chan, A; Jacobs, DJ; Vreeburg, SA; Priest, KR
Australian & New Zealand Journal of Obstetrics & Gynaecology, 44(5): 404-409.

Journal of Maternal-Fetal & Neonatal Medicine
Characteristics of preeclampsia- and eclampsia-related maternal death in rural Haiti
Small, MJ; Kershaw, T; Frederic, R; Blanc, C; Neale, D; Copel, J; Williams, KP
Journal of Maternal-Fetal & Neonatal Medicine, 18(5): 343-348.
10.1080/14767050500312433
CrossRef
International Journal of Gynecology & Obstetrics
Pregnancy outcomes of women with eclampsia in Gombe, Nigeria
Melah, GS; Massa, AA; El-Nafaty, AU
International Journal of Gynecology & Obstetrics, 92(3): 251-252.
10.1016/j.ijgo.2005.10.029
CrossRef
International Journal of Gynecology & Obstetrics
Maternal deaths due to eclampsia and HELLP syndrome
Vigil-De Gracia, P
International Journal of Gynecology & Obstetrics, 104(2): 90-94.
10.1016/j.ijgo.2008.09.014
CrossRef
Hypertension Research
Adipocytokines and endothelial function in preeclamptic women
Mori, T; Shinohara, K; Wakatsuki, A; Watanabe, K; Fujimaki, A
Hypertension Research, 33(3): 250-254.
10.1038/hr.2009.222
CrossRef
Acta Obstetricia Et Gynecologica Scandinavica
Family history of hypertension as an important risk factor for the development of severe preeclampsia
Bezerra, PCFM; Leao, MD; Queiroz, JW; Melo, EMD; Pereira, FVM; Nobrega, MH; Jeronimo, AK; Ferreira, LC; Jeronimo, SMB; de Araujo, ACPF
Acta Obstetricia Et Gynecologica Scandinavica, 89(5): 612-617.
10.3109/00016341003623720
CrossRef
American Journal of Obstetrics and Gynecology
Differential expression of TcR-CD3 zeta as evidence for altered immunoregulation in preeclamptic versus normotensive women
Lam, GK; Whitecar, PW; Orton, S; Boggess, KA; Taylor, DD
American Journal of Obstetrics and Gynecology, 189(3): 843-847.
10.1067/S0002-9378(03)00815-9
CrossRef
Cellular and Molecular Biology
ENDOGENOUS Na/K-ATPase INHIBITORS IN PATIENTS WITH PREECLAMPSIA
Averina, IV; Tapilskaya, NI; Reznik, VA; Frolova, EV; Fedorova, OV; Lakatta, EG; Bagrov, AY
Cellular and Molecular Biology, 52(8): 19-23.
10.1170/T755
CrossRef
Nutrition Reviews
Vitamin D for the prevention of preeclampsia? A hypothesis
Hypponen, E
Nutrition Reviews, 63(7): 225-232.
10.1301/nr.2005.jul.225-232
CrossRef
Clinical Science
Increased uterine arterial pressure and contractility of perfused swine uterus after treatment with serum from pre-eclamptic women and endothelin-I
Maltaris, T; Scalera, F; Schlembach, D; Hoffmann, I; Mueller, A; Binder, H; Goecke, T; Hothorn, T; Schild, RL; Beckmann, MW; Dittrich, R
Clinical Science, 109(2): 209-215.

Canadian Medical Association Journal
Headache and seizure on postpartum day 5: late postpartum eclampsia
Ginzburg, VE; Wolff, B
Canadian Medical Association Journal, 180(4): 425-428.
10.1503/cmaj.071446
CrossRef
Seminars in Perinatology
The Global Impact of Pre-eclampsia and Eclampsia
Duley, L
Seminars in Perinatology, 33(3): 130-137.
10.1053/j.semperi.2009.02.010
CrossRef
Journal of Nephrology
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up
Buemi, M; Bolignano, D; Barilla, A; Nostro, L; Crasci, E; Campo, S; Coppolino, G; D'Anna, R
Journal of Nephrology, 21(5): 663-672.

Current Vascular Pharmacology
Potential Cell Signalling Mechanisms Involved in Differential Placental Angiogenesis in Mild and Severe Pre-Eclampsia
Escudero, C; Puebla, C; Westermeier, F; Sobrevia, L
Current Vascular Pharmacology, 7(4): 475-485.

Environmental Health Perspectives
Pesticide Exposure and Hypertensive Disorders during Pregnancy
Saldana, TM; Basso, O; Baird, DD; Hoppin, JA; Weinberg, CR; Blair, A; Alavanja, MCR; Sandler, DP
Environmental Health Perspectives, 117(9): 1393-1396.
10.1289/ehp.0900672
CrossRef
Journal of Ultrasound in Medicine
Should Bilateral Uterine Artery Notching Be Used in the Risk Assessment for Preeclampsia, Small-for-Gestational-Age, and Gestational Hypertension?
Espinoza, J; Kusanovic, JP; Bahado-Singh, R; Gervasi, MT; Romero, R; Lee, W; Vaisbuch, E; Mazaki-Tovi, S; Mittal, P; Gotsch, F; Erez, O; Gomez, R; Yeo, L; Hassan, SS
Journal of Ultrasound in Medicine, 29(7): 1103-1115.

Geburtshilfe Und Frauenheilkunde
Management of preeclampsia remote from term
Coppage, KH; Sibai, BM
Geburtshilfe Und Frauenheilkunde, 64(1): 27-32.
10.1055/s-2003-44694
CrossRef
Journal of Obstetrics and Gynaecology Research
Neutrophil apoptosis in preeclampsia, do steroids confound the relationship?
Fuchisawa, A; van Eeden, S; Magee, LA; Whalen, B; Leung, PCK; Russell, JA; Walley, KR; von Dadelszen, P
Journal of Obstetrics and Gynaecology Research, 30(5): 342-348.

Placenta
Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia
Nishizawa, H; Pryor-Koishi, K; Kato, T; Kowa, H; Kurahashi, H; Udagawa, Y
Placenta, 28(): 487-497.
10.1016/j.placenta.2006.05.010
CrossRef
Best Practice & Research in Clinical Obstetrics & Gynaecology
Maternal mortality in the United States
Lang, CT; King, JC
Best Practice & Research in Clinical Obstetrics & Gynaecology, 22(3): 517-531.
10.1016/j.bpobgyn.2007.10.004
CrossRef
Annual Review of Pathology-Mechanisms of Disease
Pathogenesis of Preeclampsia
Young, BC; Levine, RJ; Karumanchi, SA
Annual Review of Pathology-Mechanisms of Disease, 5(): 173-192.
10.1146/annurev-pathol-121808-102149
CrossRef
American Journal of Epidemiology
Risk of gestational hypertension in relation to folic acid supplementation during pregnancy
Hernandez-Diaz, S; Werler, MM; Louik, C; Mitchell, AA
American Journal of Epidemiology, 156(9): 806-812.
10.1093/aje/kwf129
CrossRef
Gynecologic and Obstetric Investigation
Proteomic analysis of proteins differentially expressed in preeclamptic trophoblasts
Sun, LZ; Yang, NN; De, W; Xiao, YS
Gynecologic and Obstetric Investigation, 64(1): 17-23.
10.1159/000098399
CrossRef
American Journal of Obstetrics and Gynecology
Does maternal race or ethnicity affect the expression of severe preeclampsia?
Goodwin, AA; Mercer, BM
American Journal of Obstetrics and Gynecology, 193(3): 973-978.
10.1016/j.ajog.2005.05.047
CrossRef
International Journal of Gynecology & Obstetrics
Placental growth factor in the cerebrospinal fluid of women with preeclampsia
Foyouzi, N; Norwitz, ER; Tsen, LC; Buhimschi, CS; Buhimschi, IA
International Journal of Gynecology & Obstetrics, 92(1): 32-37.
10.1016/j.ijgo.2005.09.004
CrossRef
American Journal of Obstetrics and Gynecology
Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor
Espinoza, J; Romero, R; Nien, JK; Gomez, R; Kusanovic, JP; Goncalves, LF; Medina, L; Edwin, S; Hassan, S; Carstens, M; Gonzalez, R
American Journal of Obstetrics and Gynecology, 196(4): -.
ARTN 326.e1
CrossRef
Journal of Clinical Endocrinology & Metabolism
Maternal vitamin D deficiency increases the risk of preeclampsia
Bodnar, LM; Catov, JM; Simhan, HN; Holick, MF; Powers, RW; Roberts, JM
Journal of Clinical Endocrinology & Metabolism, 92(9): 3517-3522.
10.1210/jc.2007-0718
CrossRef
American Journal of Obstetrics and Gynecology
Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma
Purwosunu, Y; Sekizawa, A; Okazaki, S; Farina, A; Wibowo, N; Nakamura, M; Rizzo, N; Saito, H; Okai, T
American Journal of Obstetrics and Gynecology, 200(4): -.
ARTN 386.e1
CrossRef
Womens Health Issues
The Denial of Abortion Care Information, Referrals, and Services Undermines Quality Care for Us Women
Weitz, TA; Fogel, SB
Womens Health Issues, 20(1): 7-11.
10.1016/j.whi.2009.11.002
CrossRef
American Journal of Emergency Medicine
A current concept of eclampsia
Lipstein, H; Lee, CC; Crupi, RS
American Journal of Emergency Medicine, 21(3): 223-226.
10.1016/S0735-6757(02)42241-3
CrossRef
Obstetrics and Gynecology
Pregnancy-related mortality among women aged 35 years and older, United States, 1991-1997
Callaghan, WM; Berg, CJ
Obstetrics and Gynecology, 102(5): 1015-1021.
10.1016/S0029-7844(03)00740-3
CrossRef
Journal of Clinical Endocrinology & Metabolism
The intrauterine environment is a strong determinant of glucose tolerance during the neonatal period, even in prematurity
Gray, IP; Cooper, PA; Cory, BJ; Toman, M; Crowther, NJ
Journal of Clinical Endocrinology & Metabolism, 87(9): 4252-4256.
10.1210/jc.2001-011961
CrossRef
Acta Obstetricia Et Gynecologica Scandinavica
High-density lipoprotein and homocysteine levels correlate inversely in preeclamptic women in northern Nigeria
Vanderjagt, DJ; Patel, RJ; El-Nafaty, AU; Melah, GS; Crossey, MJ; Glew, RH
Acta Obstetricia Et Gynecologica Scandinavica, 83(6): 536-542.

Seminars in Perinatology
Predicting Adverse Outcomes in Women with Severe Pre-eclampsia
von Dadelszen, P; Menzies, JM; Payne, B; Magee, LA
Seminars in Perinatology, 33(3): 152-157.
10.1053/j.semperi.2009.02.009
CrossRef
Health Economics
Maternal health: does prenatal care make a difference?
Conway, KS; Kutinova, A
Health Economics, 15(5): 461-488.
10.1002/hec.1097
CrossRef
Journal of Maternal-Fetal & Neonatal Medicine
Maternal mortality rates in the last eight years: A university hospital-based study from Turkey
Malatyalioglu, E; Kokcu, A; Cetinkaya, MB; Alper, T; Tosun, M
Journal of Maternal-Fetal & Neonatal Medicine, 19(6): 353-356.
10.1080/14767050600647571
CrossRef
Biology of Reproduction
Severe feto-placental abnormalities precede the onset of hypertension and proteinuria in a mouse model of preeclampsia
Dokras, A; Hoffmann, DS; Eastvold, JS; Kienzle, MF; Gruman, LM; Kirb, PA; Weiss, RM; Davisson, RL
Biology of Reproduction, 75(6): 899-907.
10.1095/biolreprod.106.053603
CrossRef
American Journal of Emergency Medicine
Diagnosis and management of labile blood pressure during acute cerebrovascular accidents and other hypertensive crises
Varon, J
American Journal of Emergency Medicine, 25(8): 949-959.
10.1016/j.ajem.2007.02.032
CrossRef
Neurologic Clinics
Stroke in Women: Risk and Prevention Throughout the Lifespan
Bushnell, CD
Neurologic Clinics, 26(4): 1161-1176.
10.1016/j.ncl.2008.05.009
CrossRef
Prenatal Diagnosis
Early onset preeclampsia and second trimester serum markers
Lambert-Messerlian, GM; Palomaki, GE; Neveux, LM; Chien, E; Friedman, A; Rosene-Montella, K; Hayes, M; Canick, JA
Prenatal Diagnosis, 29(): 1109-1117.
10.1002/pd.2387
CrossRef
Placenta
Dynamics of placental ghrelin production and its receptor expression in a Dahl salt-sensitive rat model of intrauterine growth restriction
Nonoshita, A; Nishi, Y; Takushima, S; Oshima, M; Hosoda, H; Kangawa, K; Kojima, M; Mifune, H; Tanaka, E; Hori, D; Kamura, T
Placenta, 31(5): 358-364.
10.1016/j.placenta.2010.02.013
CrossRef
Hypertension
Cerebral blood flow autoregulation and edema formation during pregnancy in anesthetized rats
Euser, AG; Cipolla, MJ
Hypertension, 49(2): 334-340.
10.1161/01.HYP.0000255791.54655.29
CrossRef
Journal of Perinatal Medicine
Adiponectin in severe preeclampsia
Nien, JK; Mazaki-Tovi, S; Romero, R; Erez, O; Kusanovic, JP; Gotsch, F; Pineles, BL; Gomez, R; Edwin, S; Mazor, M; Espinoza, J; Yoon, BH; Hassan, SS
Journal of Perinatal Medicine, 35(6): 503-512.
10.1515/JPM.2007.121
CrossRef
Maternal and Child Health Journal
Racial disparity in infant and maternal mortality: Confluence of infection, and microvascular dysfunction
Fiscella, K
Maternal and Child Health Journal, 8(2): 45-54.

American Journal of Obstetrics and Gynecology
Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia
Buhimschi, CS; Norwitz, ER; Funai, E; Richman, S; Guller, S; Lockwood, CJ; Buhimschi, IA
American Journal of Obstetrics and Gynecology, 192(3): 734-741.
10.1016/j.ajog.2004.12.052
CrossRef
Bjog-An International Journal of Obstetrics and Gynaecology
Relationship between high consumption of marine fatty acids in early pregnancy and hypertensive disorders in pregnancy
Olafsdottir, AS; Skuladottir, GV; Thorsdottir, I; Hauksson, A; Thorgeirsdottir, H; Steingrimsdottir, L
Bjog-An International Journal of Obstetrics and Gynaecology, 113(3): 301-309.
10.1111/j.1471-0528.2005.00826.x
CrossRef
Hypertension in Pregnancy
A comparison of walking versus stretching exercises to reduce the incidence of preeclampsia: A randomized clinical trial
Yeo, S; Davidge, S; Ronis, DL; Antonakos, CL; Hayashi, R; O'Leary, S
Hypertension in Pregnancy, 27(2): 113-130.
10.1080/10641950701826778
CrossRef
Hypertension in Pregnancy
In Vitro Fertilization is Associated with an Increased Risk for Preeclampsia
Chen, XK; Wen, SW; Bottomley, J; Smith, GN; Leader, A; Walker, MC
Hypertension in Pregnancy, 28(1): 1-12.
10.1080/10641950802001859
CrossRef
Placenta
Novel Splice Variants of sFlt1 are Upregulated in Preeclampsia
Heydarian, M; McCaffrey, T; Florea, L; Yang, Z; Ross, MM; Zhou, W; Maynard, SE
Placenta, 30(3): 250-255.
10.1016/j.placenta.2008.12.010
CrossRef
Journal of Reproductive Immunology
The link between insulin resistance and preeclampsia: new perspectives
Scioscia, M; Gumaa, K; Rademacher, TW
Journal of Reproductive Immunology, 82(2): 100-105.
10.1016/j.jri.2009.04.009
CrossRef
Thrombosis Research
Changes of plasma and placental tissue factor pathway inhibitor-2 in women with preeclampsia and normal pregnancy
Xiong, Y; Zhou, QJ; Jiang, FL; Zhou, SF; Lou, YT; Guo, QS; Liang, W; Kong, DS; Ma, D; Li, XT
Thrombosis Research, 125(6): E317-E322.
10.1016/j.thromres.2010.02.017
CrossRef
Hypertension in Pregnancy
Subclassification of preeclampsia
von Dadelszen, P; Magee, LA; Roberts, JM
Hypertension in Pregnancy, 22(2): 143-148.
10.1081/PRG-120021060
CrossRef
Prenatal Diagnosis
Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop preeclampsia later in pregnancy: implications for screening
Farina, A; Morano, D; Arcelli, D; De Sanctis, P; Sekizawa, A; Purwosunu, Y; Zucchini, C; Simonazzi, G; Okai, T; Rizzo, N
Prenatal Diagnosis, 29(): 1038-1044.
10.1002/pd.2344
CrossRef
Ultrasound in Obstetrics & Gynecology
Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation
Yu, CKH; Papageorghiou, AT; Parra, M; Dias, RP; Nicolaides, KH
Ultrasound in Obstetrics & Gynecology, 22(3): 233-239.
10.1002/uog.218
CrossRef
International Journal of Obstetric Anesthesia
Maternal and fetal outcome of anaesthesia for caesarean delivery in preeclampsia/eclampsia in Enugu, Nigeria: a retrospective observational study
Okafor, UV; Okezie, O
International Journal of Obstetric Anesthesia, 14(2): 108-113.
10.1016/j.ijoa.2004.10.011
CrossRef
Paediatric and Perinatal Epidemiology
Safe motherhood in Jamaica: from slavery to self-determination
McCaw-Binns, A
Paediatric and Perinatal Epidemiology, 19(4): 254-U1.

Clinical Chemistry
Protein: Creatinine ratio in random urine samples is a reliable marker of increased 24-hour protein excretion in hospitalized women with hypertensive disorders of pregnancy
Leanos-Miranda, A; Marquez-Acosta, J; Romero-Arauz, F; Cardenas-Mondragon, GM; Rivera-Leanos, R; Isordia-Salas, I; Ulloa-Aguirre, A
Clinical Chemistry, 53(9): 1623-1628.
10.1373/clinchem.2007.089334
CrossRef
Acta Bioquimica Clinica Latinoamericana
Evaluation of maternal-fetal risks and reference values in pregnancy
[Anon]
Acta Bioquimica Clinica Latinoamericana, 41(4): 563-586.

Prenatal Diagnosis
Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia
Farina, A; Sekizawa, A; De Sanctis, P; Purwosunu, Y; Okai, T; Cha, DH; Kang, JH; Vicenzi, C; Tempesta, A; Wibowo, N; Valvassori, L; Rizzo, N
Prenatal Diagnosis, 28(): 956-961.
10.1002/pd.2109
CrossRef
Journal De Gynecologie Obstetrique Et Biologie De La Reproduction
Latest developments: Management and treatment of preeclampsia
Winer, N; Tsasaris, V
Journal De Gynecologie Obstetrique Et Biologie De La Reproduction, 37(1): 5-15.
10.1016/j.jgyn.2007.09.008
CrossRef
Journal of Maternal-Fetal & Neonatal Medicine
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia
Kusanovic, JP; Romero, R; Chaiworapongsa, T; Erez, O; Mittal, P; Vaisbuch, E; Mazaki-Tovi, S; Gotsch, F; Edwin, SS; Gomez, R; Yeo, L; Conde-Agudelo, A; Hassan, SS
Journal of Maternal-Fetal & Neonatal Medicine, 22(): 1021-1038.
10.3109/14767050902994754
CrossRef
Australian & New Zealand Journal of Obstetrics & Gynaecology
Risk factors for hypertension during pregnancy in South Australia
Jacobs, DJ; Vreeburg, SA; Dekker, GA; Heard, AR; Priest, KR; Chan, A
Australian & New Zealand Journal of Obstetrics & Gynaecology, 43(6): 421-428.

Proceedings of the Xvii Meeting International Society of Haematology (European and African Division)
Can the free forms of TFPI and free protein S be the hallmark of the coagulopathy of pre-eclampsia?
Gader, AMA; Al-Mishari, AA; Buyuomi, NM; Khashoggi, T; Al-Hakeem, M
Proceedings of the Xvii Meeting International Society of Haematology (European and African Division), (): 187-192.

Thrombosis and Haemostasis
Efficacy of AT in pre-eclampsia: a case-control prospective trial
Paternoster, DM; Fantinato, S; Manganelli, F; Milani, M; Nicolini, U; Girolami, A
Thrombosis and Haemostasis, 91(2): 283-289.
10.1160/TH03-06-0388
CrossRef
International Journal of Gynecology & Obstetrics
Hypertensive disorders of pregnancy
Zareian, Z
International Journal of Gynecology & Obstetrics, 87(2): 194-198.
10.1016/j.ijgo.2004.06.016
CrossRef
Hypertension in Pregnancy
The correlation between renal function and systolic or diastolic blood pressure in severe preeclamptic women
Seow, KM; Tang, MH; Chuang, J; Wang, YY; Chen, DC
Hypertension in Pregnancy, 24(3): 247-257.
10.1080/10641950500281126
CrossRef
Geburtshilfe Und Frauenheilkunde
Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of NO synthase - also a risk marker for preeclampsia?
Maas, R; Baschat, A; Hecher, K; Boger, RH
Geburtshilfe Und Frauenheilkunde, 67(6): 611-+.
10.1055/s-2007-965092
CrossRef
Hypertension in Pregnancy
Serum Inhibin A Level in Preeclampsia and Normotensive Pregnancy
Paiwattananupant, K; Phupong, V
Hypertension in Pregnancy, 27(4): 337-343.
10.1080/10641950802020545
CrossRef
Reproductive Biology and Endocrinology
Mouse models for preeclampsia: disruption of redox-regulated signaling
Banerjee, S; Randeva, H; Chambers, AE
Reproductive Biology and Endocrinology, 7(): -.
ARTN 4
CrossRef
Bjog-An International Journal of Obstetrics and Gynaecology
The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio
Buhimschi, CS; Baumbusch, MA; Dulay, AT; Lee, S; Wehrum, M; Zhao, G; Bahtiyar, MO; Pettker, CM; Ali, UA; Funai, EF; Buhimschi, IA
Bjog-An International Journal of Obstetrics and Gynaecology, 117(3): 321-330.
10.1111/j.1471-0528.2009.02434.x
CrossRef
Nefrologia
Severe pathology associated with pre-eclampsia: Complications almost forgotten
Navascues, RA; Marin, R
Nefrologia, 21(6): 565-573.

Clinics in Laboratory Medicine
Autoimmune disease as a cause of reproductive failure
Rote, NS; Stetzer, BP
Clinics in Laboratory Medicine, 23(2): 265-+.
10.1016/S0272-2712(03)00022-2
CrossRef
Annals of Saudi Medicine
Partial recovery of the visual field scotoma upon early retinal photocoagulation and the medical therapy in a preeclamptic patient
Akar, ME; Apaydin, C; Akar, Y
Annals of Saudi Medicine, 24(6): 487-488.

Clinical Chemistry and Laboratory Medicine
Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status
Herrmann, W; Isber, S; Obeid, R; Herrmann, M; Jouma, M
Clinical Chemistry and Laboratory Medicine, 43(): 1139-1146.
10.1515/CCLM.2005.198
CrossRef
Journal of Womens Health
Changes in health status experienced by women with gestational diabetes and pregnancy-induced hypertensive disorders
Kim, C; Brawarsky, P; Jackson, RA; Fuentes-Afflick, E; Haas, JS
Journal of Womens Health, 14(8): 729-736.

American Journal of Psychiatry
Selective Serotonin Reuptake Inhibitor Use and Risk of Gestational Hypertension
Toh, S; Mitchell, AA; Louik, C; Werler, MM; Chambers, CD; Hernandez-Diaz, S
American Journal of Psychiatry, 166(3): 320-328.
10.1176/appi.ajp.2008.08060817
CrossRef
Prenatal Diagnosis
The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia
Kim, YN; Lee, DS; Jeong, DH; Sung, MS; Kim, KT
Prenatal Diagnosis, 29(5): 464-470.
10.1002/pd.2203
CrossRef
American Journal of Obstetrics and Gynecology
Implications of vitamin D deficiency in pregnancy and lactation
Mulligan, ML; Felton, SK; Riek, AE; Bernal-Mizrachi, C
American Journal of Obstetrics and Gynecology, 202(5): -.
ARTN 429.e1
CrossRef
Family Planning Perspectives
Preeclampisa and eclampsia, while often preventable, are among top causes of pregnancy-related deaths
Hirozawa, A
Family Planning Perspectives, 33(4): 182-183.

Bjog-An International Journal of Obstetrics and Gynaecology
Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia
von Dadelszen, P; Magee, LA; Krajden, M; Alasaly, K; Popovska, V; Devarakonda, RM; Money, DM; Patrick, DM; Brunhame, RC
Bjog-An International Journal of Obstetrics and Gynaecology, 110(8): 725-730.
PII S1470-0328(03)02481-9
CrossRef
Drugs
Regional anaesthesia in pre-eclampsia advantages and disadvantages
Mandal, NG; Surapaneni, S
Drugs, 64(3): 223-236.

Clinical Drug Investigation
Depression during pregnancy - Overview of clinical factors
Bennett, HA; Einarson, A; Taddio, A; Koren, G; Einarson, TR
Clinical Drug Investigation, 24(3): 157-179.

Critical Care Clinics
Pregnancy-associated severe liver dysfunction
Steingrub, JS
Critical Care Clinics, 20(4): 763-+.
10.1016/j.ccc.2004.05.006
CrossRef
American Journal of Obstetrics and Gynecology
Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia
Hamar, BD; Buhimschi, IA; Sfakianaki, AK; Pettker, CM; Magloire, LK; Funai, EF; Copel, JA; Buhimschi, CS
American Journal of Obstetrics and Gynecology, 195(6): 1636-1645.
10.1016/j.ajog.2006.05.019
CrossRef
Frontiers in Bioscience
Matrix metalloproteinases: control of vascular function and their potential role in preeclampsia
Lalu, MM; Xu, H; Davidge, ST
Frontiers in Bioscience, 12(): 2484-2493.

Turkish Journal of Medical Sciences
Placental heat shock protein 70 overexpression confers resistance against oxidative stress in preeclampsia
Padmini, E; Geetha, BV
Turkish Journal of Medical Sciences, 38(1): 27-34.

Critical Care Medicine
Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: A therapeutic opportunity?*
von Dadelszen, P; Magee, LA; Lee, SK; Stewart, SD; Simone, C; Koren, G; Walley, KR; Russell, JA
Critical Care Medicine, 30(8): 1883-1892.

PDF (1525)
Clinical Obstetrics and Gynecology
Eclampsia: Morbidity, Mortality, and Management
Aagaard-Tillery, KM; Belfort, MA
Clinical Obstetrics and Gynecology, 48(1): 12-23.
10.1097/01.grf.0000153882.58132.ba
PDF (96) | CrossRef
Clinical Obstetrics and Gynecology
Acute Complications of Preeclampsia
NORWITZ, ER; HSU, C; REPKE, JT
Clinical Obstetrics and Gynecology, 45(2): 308-329.

PDF (977)
Current Opinion in Obstetrics and Gynecology
Hypertensive diseases and eclampsia
Myers, JE; Baker, PN
Current Opinion in Obstetrics and Gynecology, 14(2): 119-125.

PDF (152)
Genetics in Medicine
Effects of pregnancy on the renal and pulmonary manifestations in women with tuberous sclerosis complex
Mitchell, AL; Parisi, MA; Sybert, aP
Genetics in Medicine, 5(3): 154-160.

PDF (222)
Obstetrics & Gynecology
Diagnosis, Prevention, and Management of Eclampsia
Sibai, BM
Obstetrics & Gynecology, 105(2): 402-410.
10.1097/01.AOG.0000152351.13671.99
PDF (253) | CrossRef
Obstetrics & Gynecology
Second‐Trimester Maternal Serum Placental Growth Factor and Vascular Endothelial Growth Factor for Predicting Severe, Early‐Onset Preeclampsia
Polliotti, BM; Fry, AG; Saller, DN; Mooney, RA; Cox, C; Miller, RK
Obstetrics & Gynecology, 101(6): 1266-1274.

PDF (160)
Obstetrics & Gynecology
Incidence and Risk Factors for Stroke in Pregnancy and the Puerperium
James, AH; Bushnell, CD; Jamison, MG; Myers, ER
Obstetrics & Gynecology, 106(3): 509-516.
10.1097/01.AOG.0000172428.78411.b0
PDF (232) | CrossRef
Journal of Hypertension
Low socioeconomic status is a risk factor for preeclampsia: the Generation R Study
Silva, LM; Coolman, M; Steegers, EA; Jaddoe, VW; Moll, HA; Hofman, A; Mackenbach, JP; Raat, H
Journal of Hypertension, 26(6): 1200-1208.
10.1097/HJH.0b013e3282fcc36e
PDF (146) | CrossRef
Obstetrical & Gynecological Survey
Vitamin D May Be a Link to Black-White Disparities in Adverse Birth Outcomes
Bodnar, L; Simhan, H
Obstetrical & Gynecological Survey, 65(4): 273-284.
10.1097/OGX.0b013e3181dbc55b
PDF (428) | CrossRef
Obstetrical & Gynecological Survey
Late Postpartum Eclampsia: Examples and Review
Hirshfeld-Cytron, J; Lam, C; Karumanchi, SA; Lindheimer, M
Obstetrical & Gynecological Survey, 61(7): 471-480.
10.1097/01.ogx.0000219564.65999.0d
PDF (453) | CrossRef
Obstetrical & Gynecological Survey
Preeclampsia. Part 1: Clinical and Pathophysiologic Considerations
Pridjian, G; Puschett, JB
Obstetrical & Gynecological Survey, 57(9): 598-618.

PDF (1050)
Simulation in Healthcare
Prospective Randomized Trial of Simulation Versus Didactic Teaching for Obstetrical Emergencies
Daniels, K; Arafeh, J; Clark, A; Waller, S; Druzin, M; Chueh, J
Simulation in Healthcare, 5(1): 40-45.
10.1097/SIH.0b013e3181b65f22
PDF (278) | CrossRef
Southern Medical Journal
Preeclampsia and Eclampsia Revisited
Longo, SA; Dola, CP; Pridjian, G
Southern Medical Journal, 96(9): 891-899.

PDF (93)
Back to Top | Article Outline

© 2001 The American College of Obstetricians and Gynecologists

Login

Article Tools

Images

Share